论文部分内容阅读
宫颈癌是妇科常见恶性肿瘤。据报道,2008年全球约530,000妇女确诊为宫颈癌,275,000妇女死于宫颈癌[1]。新发宫颈癌病例80%集中在发展中国家。宫颈癌的防治成为全世界探讨的公共卫生问题。宫颈液基细胞学(TCT)检测用于早期发现宫颈癌癌前病变,较传统的宫颈细胞巴氏涂片(CS)更准确,已经作为宫颈癌早期筛查首选方法[2]。本文回顾性分析在浙江大学医学院附属妇产科医院(省妇保院)门诊就诊,并自愿接受
Cervical cancer is a common gynecological cancer. It is reported that in 2008 about 530,000 women worldwide were diagnosed with cervical cancer and 275,000 women died of cervical cancer [1]. Eighty percent of new cases of cervical cancer are concentrated in developing countries. Prevention and treatment of cervical cancer has become the world’s public health issue. Cervical liquid-based cytology (TCT) detection of early detection of cervical precancerous lesions, more than the traditional cervical smear (CS) more accurate, has been used as a screening method of cervical cancer early choice [2]. This article retrospectively analyzed in Zhejiang University School of Medicine Obstetrics and Gynecology Hospital (Provincial Women’s Hospital) out-patient treatment, and voluntarily accept